Health article writer and researcher; Over 10.000 articles and research papers have been written and published on line, including world wide health, ezine articles, article base, healthblogs, selfgrowth, best before it's news, the karate GB daily, etc.,.
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Disilgold.com Named 50 of the best health Tweeters Canada - Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as international journal Pharma and Bio science, ISSN 0975-6299.
Polycystic Ovarian Syndrome
Polycystic Ovarian Syndrome is defined as endocrinologic diseases among reproductive-age women caused by undeveloped follicles clumping on the ovaries that interferes with the function of the normal ovaries associated with a high risk for metabolic disorder(1) as resulting of enlarged ovaries(2), leading to hormone imbalance(excessive androgen and anti-müllerian hormone (AMH) )(1)(3)(4)(5), induced Hirsutism(6)(7), reproductive disorder(10(12)), risks of type 2 diabetes(9)(10)(11), metabolic syndrome(10)(12) and early cardiovasular disease(8)(13), acne(10)(14), endometrial cance(18)(19),weight gain and obesity(15)(16)(17). The syndrome effects over 5% of women population or 1 in 20 women.
Unfortunately, according to studies, women with PCOs after the reproductive age, are associated to continuously increase risk of type II diabetes, with no increasing altered glucose tolerance(20), CVD and hypertension(21).
In Traditional Chinese Medicine Perspective
While conventional medicine focus of using synthetic medication to induce ovulation and assisted artificial insemination for infertility couple, if the medicine fail, traditional Chinese medicine views polycystic ovarian syndrome in different approaches.Polycystic ovary syndrome, according to traditional Chinese medicine is a medical condition characterized by accumulative of fluid over a prolonged period of time causes of dampness and phlegms(247a)(247b) build up on the ovaries due to the effects of vary differentiations, affecting not only the women’s menstrual cycle, but also ovulation and fertility(1247a)(247b).
Dietary Suggestion, Life Style Modification and Nutritional Supplements according to TCM
According to Angela Warburton(1249), a doctor of Traditional Chinese Medicine practicing in Toronto, Canada, incorporating the proper dietary and lifestyle modifications, may make a BIG difference in the long-term for treatment of PCOs(1249).
PCOs Treatment according traditional Chinese medicine
Depending to differentiation, most common diagnosis of polycystic ovary syndrome can be classified into
Spleen yang deficiency
Spleen yang deficiency is a serve form of spleen qi deficiency, characterized by a condition of inability of spleen in distribution of fluid and nutrient to the body organs, in removal and descend the turbids(2072), causing malfunctions functions of the organs and fluid retention. Prolong period of spleen yang deficiency may induce the development of phlegm, including women with PCOs.
Women with PCOs diagnosed by spleen yang deficiency may also experience yang vacuity impelled cold expression of additional symptoms of abdominal pain(2074), lack of appetite(2076), fatigue(2075), lightheadedness(2075) and headache(2075), weakness of the four limbs(2077), diarrhea(2073)(2076), chilliness(2077), edema(2074), pale, swollen, wet tongue(2076) and weak, slow, deep pulse(2072),....
In the review of the Data base provided by PubMed, spleen qi deficiency may alter certain metabolic pathways, such as the energy, protein, and glycolytic metabolisms(2078), body weight and motor behavior(2079), skeletal muscle function(3080), blood glucose, lipid metabolism and fat-islet axie.(2081),.....
Foods for Spleen yang deficiency
Spleen yang deficiency can be managed and treated in part with a diet of fresh and cooked warming foods.
6. Turmeric
Turmeric is a perennial plant in the genus Curcuma, belonging to the family Zingiberaceae, native to tropical South Asia. The herb has been used in traditional Chinese medicine for its effect on high lipids (2118)(2119), pain(2120)(2121), rheumatoid arthritis inflammation(2122)(2123), periodontitis(2124)(2125), tumors(2126)(2127)(2128), herpes(2129)(2130), coronary atherosclerosis(2131)(2132), neurodegeneration(2133)(2134), leukemia(2135)(2136),.............. as the acrid, bitter, aromatic, warm food enhances the stomach, liver, spleen channels(2117).
Phytochemical constituents(2117)
1. Beberine
2. Tumerone
3. Dihydroturmerone
4. Curcumin
5. Demethoxycurcumin
6. Bisdemethoxycurcumin
7. Borneol
8. Zingberene
9. Arabic gum
10. Curcumol
11. Zingiberen
12. Phellandrene
13. Eucalyptol
14. Etc.
In metabolic syndrome differentiation(2137)(2138), turmeric has shown to reduce risk of complications of diabetes and cardiovascular disease(2145) through attenuated expression of, lipid-profile (cholesterol, HDL-cholesterol, LDL-cholesterol and TG)(2137)(2138), fasting glucose(2137)(2138) hypoglycemia(2139)(2140)(2142) and hypolipidemia(2139)(2141)(2142), weigh loss(2138)[body mass index and waist circumference)], insulin resistance(2144)(2143), hypertension(2145)(2146), obesity(2147), c-reactive protein (CRP)(2137)....via glucose and lipid metabolic (2148)(2149), antioxidants(2150)(2151)(2152) and anti inflammatory(2153)(2154)(2155) pathways.
Berberine (BBR), its major chemical constituents also exerted the effect in improving some of the metabolic(829) and hormonal derangements in a group of treated Chinese women with PCOS(829).
Arthritis Is Curable
You Can Eliminate Osteoarthritis
By addressing the Underlying Causes through Clinical Trials and Studies
Ovarian Cysts And PCOS Elimination
Holistic System In Existence That Will Show You How To
Permanently Eliminate All Types of Ovarian Cysts Within 2 Months
Super foods Library, Eat Yourself Healthy With The Best of the Best Nature Has to Offer recommended by Kyle J. Norton
Back to Kyle J. Norton Home page http://kylejnorton.blogspot.caReferences
(1) Adiposity and metabolic dysfunction in polycystic ovary syndrome by Sam S.(PubMed)
(2) A "kiss" before conception: triggering ovulation with kisspeptin-54 may improve IVF by Young SL.(PubMed)
(3.) Androgen hyperfunction and excessive heterosexual hair growth in women, with special attention to the polycystic ovarian syndrome by Lunde O1.(PubMed)
(4) Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome by Du DF1, Li XL, Fang F, Du MR.(PubMed)
(5) [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].[Article in Bulgarian] by Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.(PubMed)
(6) [Current opinions on the etiology and pathophysiology of hirsutism].[Article in Polish] by Krysiak R1, Kedzia A, Okopień B.(PubMed)
(7) The clinical evaluation of hirsutism by Somani N1, Harrison S, Bergfeld WF.(PubMed)
(8) Polycystic ovary syndrome and insulin: our understanding in the past, present and future by Mayer SB1, Evans WS, Nestler JE.(PubMed)
(9) Association of mean platelet volume with androgens and insulin resistance in nonobese patients with polycystic ovary syndrome by Dogan BA1, Arduc A2, Tuna MM1, Karakılıc E1, Dagdelen I1, Tutuncu Y1, Berker D1, Guler S1.(PubMed)
(10) Approach to the patient: contraception in women with polycystic ovary syndrome by Yildiz BO1.(PubMed)
(11) Polycystic ovarian syndrome (PCOS): a significant contributor to the overall burden of type 2 diabetes in women by Talbott EO1, Zborowski JV, Rager JR, Kip KE, Xu X, Orchard TJ.(PubMed)
(12) Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities by Figurová J1, Dravecká I, Javorský M, Petríková J, Lazúrová I.(PubMed)
(13) Role of Insulin Sensitizers on Cardiovascular Risk Factors in Polycystic Ovarian Syndrome: A Meta-Analysis by Thethi TK1, Katalenich B2, Nagireddy P3, Chabbra P4, Kuhadiya N5, Fonseca V1.(PubMed)
(14) Acne in hirsute women by Lumezi BG1, Pupovci HL1, Berisha VL1, Goçi AU2, Gerqari A3.(PubMed)
(15) Obesity and polycystic ovary syndrome by Naderpoor N1, Shorakae S, Joham A, Boyle J, De Courten B, Teede HJ.(PubMed)
(16) Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan by Teede H1, Deeks A, Moran L.(PubMed)
(17) Metabolic Evidence of Diminished Lipid Oxidation in Women WithPolycystic Ovary Syndrome. by Whigham LD1, Butz DE2, Dashti H3, Tonelli M3, Johnson LK1, Cook ME2, Porter WP4, Eghbalnia HR5, Markley JL6, Lindheim SR7, Schoeller DA8, Abbott DH9, Assadi-Porter FM10.(PubMed)
(18) Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis by Barry JA1, Azizia MM1, Hardiman PJ2.(PubMed)
(19) Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study by Gottschau M1, Kjaer SK2, Jensen A1, Munk C1, Mellemkjaer L3.(PubMed)
(20) Polycystic ovary syndrome: metabolic consequences and long-term management by Carmina E1.(PubMed)
(21) Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype by Armeni E1, Stamatelopoulos K, Rizos D, Georgiopoulos G, Kazani M, Kazani A, Kolyviras A, Stellos K, Panoulis K, Alexandrou A, Creatsa M, Papamichael C, Lambrinoudaki I.(PubMed)
(1246) [Clinical study of area of Jiangsu province of polycystic ovarian syndrome correlation distribution of traditional Chinese medicine syndrome type and improper diet]. [Article in Chinese] by Feng Y, Gao YP.(PubMed)
(1247) [Preliminary study on relationship of disease-syndrome-symptom of ovulatory disorder infertility based on factor analysis]. [Article in Chinese] by Li M, Ma K, Shan, J.(PubMed)
(1247a) A Comprehensive Treatment of Polycystic Ovarian Syndrome (PCOS) bny by Liqin Zhao
(2072) Spleen, Earth
(2073) [Research on building method of spleen kidney Yang deficiency diarrhea rats model]. [Article in Chinese] by Pan X, Hu CJ, Geng YY, Zhao L, Wu WH, Wu XQ, Zhong ZD.(PubMed)
(2074) Treatment of an elderly patient with acute abdominal pain with traditional Korean medicine by Son CG1.(PubMed)
(2075) Shenzhu Tiaopi granule combined with lifestyle intervention therapy for impaired glucose tolerance: a randomized controlled trial by Fang Z1, Zhao J2, Shi G3, Shu Y3, Ni Y3, Wang H3, Ding L3, Lu R3, Li J3, Zhu X3, Cheng S4, Zhang X3, Liu Y5, Wang J6, Luo Y3, Fan Q3, Guo C3, Jiang T3, Wu Q3, Fan L3, Ling H3, Cui L3, Luo Y3, Yang H3, Anderson RM7.(PubMed)
(2075) Direct moxibustion to treat spleen qi and yang deficiency fatigue: a pilot study by Thorne TL1, Hanes DA2, Wild H3, Colbert A4.(PubMed)
(2076) [Clinical observation on fuzhong (supporting the middle-jiao) manipulation of tuina for infantile anorexia]. [Article in Chinese] by Wang YY, Liu XY.(PubMed)
(2077) [Effect of umbilicus moxibustion therapy on physical conditions of yang-deficiency volunteers]. [Article in Chinese] by Zhang YY1.(PubMed)
(2078) Analysis of the restorative effect of Bu-zhong-yi-qi-tang in the spleen-qi deficiency rat model using (1)H-NMR-based metabonomics by Zheng XF1, Tian JS2, Liu P3, Xing J1, Qin XM1.(PubMed)
(2079) [1H NMR based metabolomics study of bu-zhong-yi-qi-tang in the spleen-qi deficiency rat model]. [Article in Chinese] by Chen L, Xiang H, Xing J, Tian JS, Qin XM, Du GH.(PubMed)
(2080) Bufei Jianpi granules improve skeletal muscle and mitochondrial dysfunction in rats with chronic obstructive pulmonary disease by Dong Y1,2, Li Y3,4,5, Sun Y6, Mao J7, Yao F8, Tian Y9, Wang L10, Li L11, Li S12,13,14, Li J15,16,17(PubMed)
(2081) [Clinical observation on obesity and hyperlipidemia of liver qi stagnation and spleen deficiency pattern in female patients treated with combined therapy of acupuncture and tapping method]. [Article in Chinese] by Wu B, Liu ZC, Xu B.(PubMed)
(2117) Jiang huang(Complementary and Alternative Healing University)
(2118) Effects of ingested turmeric oleoresin on glucose and lipid metabolisms in obese diabetic mice: a DNA microarray study by Honda S1, Aoki F, Tanaka H, Kishida H, Nishiyama T, Okada S, Matsumoto I, Abe K, Mae T.(PubMed)
(2119) Herbal composition Gambigyeongsinhwan (4) from curcuma longa, Alnus japonica, and massa Medicata Fermentata inhibits lipid accumulation in 3T3-L1 cells and regulates obesity in Otsuka long-Evans Tokushima fatty rats by Sung Roh J1, Lee H2, Woo S2, Yoon M2, Kim J2, Dong Park S3, Shik Shin S4, Yoon M5.(PubMed)
(2120) Efficacy of turmeric (curcumin) in pain and postoperative fatigue after laparoscopic cholecystectomy: a double-blind, randomized placebo-controlled study by Agarwal KA1, Tripathi CD, Agarwal BB, Saluja S.(PubMed)
(2121) Intrathecal curcumin attenuates pain hypersensitivity and decreases spinal neuroinflammation in rat model of monoarthritis by Chen JJ1, Dai L2, Zhao LX3, Zhu X4, Cao S4, Gao YJ3.(PubMed)
(2122) Turmeric extracts containing curcuminoids prevent experimental rheumatoid arthritis by Funk JL1, Oyarzo JN, Frye JB, Chen G, Lantz RC, Jolad SD, Sólyom AM, Timmermann BN.(PubMed)
(2123) Efficacy and mechanism of action of turmeric supplements in the treatment of experimental arthritis by Funk JL1, Frye JB, Oyarzo JN, Kuscuoglu N, Wilson J, McCaffrey G, Stafford G, Chen G, Lantz RC, Jolad SD, Sólyom AM, Kiela PR, Timmermann BN.(PubMed)
(2124) Comparative evaluation of single application of 2% whole turmeric gel versus 1% chlorhexidine gel in chronic periodontitis patients: A pilot study by Jaswal R1, Dhawan S1, Grover V1, Malhotra R1.(PubMed)
(2125) Evaluation of local drug-delivery system containing 2% whole turmeric gel used as an adjunct to scaling and root planing in chronic periodontitis: A clinical and microbiological study by Behal R1, Mali AM, Gilda SS, Paradkar AR.(PubMed)
(2126) Chemopreventive effect of turmeric against stomach and skin tumors induced by chemical carcinogens in Swiss mice by Azuine MA1, Bhide SV.(PubMed)
(2127) Adjuvant chemoprevention of experimental cancer: catechin and dietary turmeric in forestomach and oral cancer models by Azuine MA1, Bhide SV.(PubMed)
(2128) Combination Efficacy of Astragalus membranaceus and Curcuma wenyujin at Different Stages of Tumor Progression in an Imageable Orthotopic Nude Mouse Model of Metastatic Human Ovarian Cancer Expressing Red Fluorescent Protein by Yin G1, Tang D2, Dai J1, Liu M1, Wu M1, Sun YU3, Yang Z4, Hoffman RM5, Li L1, Zhang S1, Guo X1.(PubMed)
(2129) Curcumin inhibits herpes simplex virus immediate-early gene expression by a mechanism independent of p300/CBP histone acetyltransferase activity by Kutluay SB1, Doroghazi J, Roemer ME, Triezenberg SJ.(PubMed)
(2130) Downregulation of cellular c-Jun N-terminal protein kinase and NF-κB activation by berberine may result in inhibition of herpes simplex virus replication by Song S1, Qiu M1, Chu Y1, Chen D1, Wang X1, Su A1, Wu Z2.(PubMed)
(2131) Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis by Sahebkar A1.(PubMed)
(2132) Therapeutic roles of curcumin: lessons learned from clinical trials by Gupta SC1, Patchva S, Aggarwal BB.(PubMed)
(2133) Spicing up endogenous neural stem cells: aromatic-turmerone offers new possibilities for tackling neurodegeneration by Poser SW, Androutsellis-Theotokis A.(PubMed)
(2134) Aromatic-turmerone induces neural stem cell proliferation in vitro and in vivo by Hucklenbroich J1,2, Klein R3,4, Neumaier B5, Graf R6, Fink GR7,8, Schroeter M9,10,11, Rueger MA12,13,14.(PubMed)
(2135) Turmeric and green tea: a recipe for the treatment of B-chronic lymphocytic leukemia by Angelo LS1, Kurzrock R.(PubMed)
(2136) Curcumin inhibits prosurvival pathways in chronic lymphocytic leukemia B cells and may overcome their stromal protection in combination with EGCG by Ghosh AK1, Kay NE, Secreto CR, Shanafelt TD.(PubMed)
(2137) Clinical efficacy of the co-administration of Turmeric and Black seeds (Kalongi) in metabolic syndrome - a double blind randomized controlled trial - TAK-MetS trial by Amin F1, Islam N2, Anila N3, Gilani AH4.(PubMed)
(2138) Effect of a Natural Supplement Containing Curcuma Longa, Guggul, and Chlorogenic Acid in Patients With Metabolic Syndrome by Patti AM1, Al-Rasadi K2, Katsiki N3, Banerjee Y4, Nikolic D1, Vanella L5, Giglio RV1, Giannone VA1, Montalto G1, Rizzo M6.(PubMed)
(2139) Hypoglycemic, hypolipidemic and antioxidant properties of combination ofCurcumin fromCurcuma longa, Linn, and partially purified product fromAbroma augusta, Linn. in streptozotocin induced diabetes by Ali Hussain HE1.(PubMed)
(2140) [Screening of pancreatic lipase and alpha-glucosidase inhibitors from Chinese dietary herbs]. [Article in Chinese] by Sun X1, Zhang K, Ji X, Wang Y, Jeffrey Z, Tong Y, Gao H, Zhang J, Wang Z.(PubMed)
(2141) Effect of curcumin on hepatic heme oxygenase 1 expression in high fat diet fed rats: is there a triangular relationship? by Öner-İyidoğan Y1, Tanrıkulu-Küçük S, Seyithanoğlu M, Koçak H, Doğru-Abbasoğlu S, Aydin AF, Beyhan-Özdaş Ş, Yapişlar H, Koçak-Toker N.(PubMed)
(2142) Short-term effect of G-400, polyherbal formulation in the management of hyperglycemia and hyperlipidemia conditions in patients with type 2 diabetes mellitus by Kurian GA1, Manjusha V2, Nair SS2, Varghese T2, Padikkala J3.(PubMed)
(2143) Anti-hyperglycemic and insulin sensitizer effects of turmeric and its principle constituent curcumin by Ghorbani Z1, Hekmatdoost A2, Mirmiran P3.(PubMed)
(2144) Improvements of insulin resistance in ovariectomized rats by a novel phytoestrogen from Curcuma comosa Roxb by Prasannarong M1, Saengsirisuwan V, Piyachaturawat P, Suksamrarn A.(PubMed)
(2145) Antioxidant and vascular protective effects of curcumin and tetrahydrocurcumin in rats with L-NAME-induced hypertension. Nakmareong S1, Kukongviriyapan U, Pakdeechote P, Donpunha W, Kukongviriyapan V, Kongyingyoes B, Sompamit K, Phisalaphong C.(PubMed)
(2146) Curcumin protects against cadmium-induced vascular dysfunction, hypertension and tissue cadmium accumulation in mice. Kukongviriyapan U1, Pannangpetch P2, Kukongviriyapan V3, Donpunha W4, Sompamit K5, Surawattanawan P6.(PubMed)
(2147) Anti-obesity effect of a standardised ethanol extract from Curcuma longa L. fermented with Aspergillus oryzae in ob/ob mice and primary mouse adipocytes by Ho JN1, Jang JY, Yoon HG, Kim Y, Kim S, Jun W, Lee J.(PubMed)
(2148) Serum metabonomic analysis of protective effects of Curcuma aromatica oil on renal fibrosis rats by Zhao L1, Zhang H1, Yang Y2, Zheng Y1, Dong M1, Wang Y1, Bai G3, Ye X3, Yan Z3, Gao H4.(PubMed)
(2149) Improvements of insulin resistance in ovariectomized rats by a novel phytoestrogen from Curcuma comosa Roxb by Prasannarong M1, Saengsirisuwan V, Piyachaturawat P, Suksamrarn A.(PubMed)
(2150) Turmerin: a water soluble antioxidant peptide from turmeric [Curcuma longa].by Srinivas L1, Shalini VK, Shylaja M.(PubMed)
(2151) Antiproliferative, protective and antioxidant effects of artichoke, dandelion, turmeric and rosemary extracts and their formulation by Menghini L1, Genovese S, Epifano F, Tirillini B, Ferrante C, Leporini L.(PubMed)
(2152) Associations between Dietary Antioxidant Intake and Metabolic Syndrome by Wei J1, Zeng C2, Gong QY1, Li XX1, Lei GH2, Yang TB1.(PubMed)
(2153) Inflammatory markers and cardiometabolic diseases by Esser N, Paquot N, Scheen AJ.(PubMed)
(2154) Human resistin and the RELM of Inflammation in diabesity by Al Hannan F1, Culligan KG2.(PubMed)
(2155) Protective effects of ginger-turmeric rhizomes mixture on joint inflammation, atherogenesis, kidney dysfunction and other complications in a rat model of human rheumatoid arthritis by Ramadan G1, El-Menshawy O.(PubMed)
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Disilgold.com Named 50 of the best health Tweeters Canada - Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as international journal Pharma and Bio science, ISSN 0975-6299.
Polycystic Ovarian Syndrome
Polycystic Ovarian Syndrome is defined as endocrinologic diseases among reproductive-age women caused by undeveloped follicles clumping on the ovaries that interferes with the function of the normal ovaries associated with a high risk for metabolic disorder(1) as resulting of enlarged ovaries(2), leading to hormone imbalance(excessive androgen and anti-müllerian hormone (AMH) )(1)(3)(4)(5), induced Hirsutism(6)(7), reproductive disorder(10(12)), risks of type 2 diabetes(9)(10)(11), metabolic syndrome(10)(12) and early cardiovasular disease(8)(13), acne(10)(14), endometrial cance(18)(19),weight gain and obesity(15)(16)(17). The syndrome effects over 5% of women population or 1 in 20 women.
Unfortunately, according to studies, women with PCOs after the reproductive age, are associated to continuously increase risk of type II diabetes, with no increasing altered glucose tolerance(20), CVD and hypertension(21).
In Traditional Chinese Medicine Perspective
While conventional medicine focus of using synthetic medication to induce ovulation and assisted artificial insemination for infertility couple, if the medicine fail, traditional Chinese medicine views polycystic ovarian syndrome in different approaches.Polycystic ovary syndrome, according to traditional Chinese medicine is a medical condition characterized by accumulative of fluid over a prolonged period of time causes of dampness and phlegms(247a)(247b) build up on the ovaries due to the effects of vary differentiations, affecting not only the women’s menstrual cycle, but also ovulation and fertility(1247a)(247b).
Dietary Suggestion, Life Style Modification and Nutritional Supplements according to TCM
According to Angela Warburton(1249), a doctor of Traditional Chinese Medicine practicing in Toronto, Canada, incorporating the proper dietary and lifestyle modifications, may make a BIG difference in the long-term for treatment of PCOs(1249).
PCOs Treatment according traditional Chinese medicine
Depending to differentiation, most common diagnosis of polycystic ovary syndrome can be classified into
Spleen yang deficiency
Spleen yang deficiency is a serve form of spleen qi deficiency, characterized by a condition of inability of spleen in distribution of fluid and nutrient to the body organs, in removal and descend the turbids(2072), causing malfunctions functions of the organs and fluid retention. Prolong period of spleen yang deficiency may induce the development of phlegm, including women with PCOs.
Women with PCOs diagnosed by spleen yang deficiency may also experience yang vacuity impelled cold expression of additional symptoms of abdominal pain(2074), lack of appetite(2076), fatigue(2075), lightheadedness(2075) and headache(2075), weakness of the four limbs(2077), diarrhea(2073)(2076), chilliness(2077), edema(2074), pale, swollen, wet tongue(2076) and weak, slow, deep pulse(2072),....
In the review of the Data base provided by PubMed, spleen qi deficiency may alter certain metabolic pathways, such as the energy, protein, and glycolytic metabolisms(2078), body weight and motor behavior(2079), skeletal muscle function(3080), blood glucose, lipid metabolism and fat-islet axie.(2081),.....
Foods for Spleen yang deficiency
Spleen yang deficiency can be managed and treated in part with a diet of fresh and cooked warming foods.
6. Turmeric
Turmeric is a perennial plant in the genus Curcuma, belonging to the family Zingiberaceae, native to tropical South Asia. The herb has been used in traditional Chinese medicine for its effect on high lipids (2118)(2119), pain(2120)(2121), rheumatoid arthritis inflammation(2122)(2123), periodontitis(2124)(2125), tumors(2126)(2127)(2128), herpes(2129)(2130), coronary atherosclerosis(2131)(2132), neurodegeneration(2133)(2134), leukemia(2135)(2136),.............. as the acrid, bitter, aromatic, warm food enhances the stomach, liver, spleen channels(2117).
Phytochemical constituents(2117)
1. Beberine
2. Tumerone
3. Dihydroturmerone
4. Curcumin
5. Demethoxycurcumin
6. Bisdemethoxycurcumin
7. Borneol
8. Zingberene
9. Arabic gum
10. Curcumol
11. Zingiberen
12. Phellandrene
13. Eucalyptol
14. Etc.
In metabolic syndrome differentiation(2137)(2138), turmeric has shown to reduce risk of complications of diabetes and cardiovascular disease(2145) through attenuated expression of, lipid-profile (cholesterol, HDL-cholesterol, LDL-cholesterol and TG)(2137)(2138), fasting glucose(2137)(2138) hypoglycemia(2139)(2140)(2142) and hypolipidemia(2139)(2141)(2142), weigh loss(2138)[body mass index and waist circumference)], insulin resistance(2144)(2143), hypertension(2145)(2146), obesity(2147), c-reactive protein (CRP)(2137)....via glucose and lipid metabolic (2148)(2149), antioxidants(2150)(2151)(2152) and anti inflammatory(2153)(2154)(2155) pathways.
Berberine (BBR), its major chemical constituents also exerted the effect in improving some of the metabolic(829) and hormonal derangements in a group of treated Chinese women with PCOS(829).
Arthritis Is Curable
You Can Eliminate Osteoarthritis
By addressing the Underlying Causes through Clinical Trials and Studies
Ovarian Cysts And PCOS Elimination
Holistic System In Existence That Will Show You How To
Permanently Eliminate All Types of Ovarian Cysts Within 2 Months
Super foods Library, Eat Yourself Healthy With The Best of the Best Nature Has to Offer recommended by Kyle J. Norton
Back to Kyle J. Norton Home page http://kylejnorton.blogspot.caReferences
(1) Adiposity and metabolic dysfunction in polycystic ovary syndrome by Sam S.(PubMed)
(2) A "kiss" before conception: triggering ovulation with kisspeptin-54 may improve IVF by Young SL.(PubMed)
(3.) Androgen hyperfunction and excessive heterosexual hair growth in women, with special attention to the polycystic ovarian syndrome by Lunde O1.(PubMed)
(4) Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome by Du DF1, Li XL, Fang F, Du MR.(PubMed)
(5) [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].[Article in Bulgarian] by Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.(PubMed)
(6) [Current opinions on the etiology and pathophysiology of hirsutism].[Article in Polish] by Krysiak R1, Kedzia A, Okopień B.(PubMed)
(7) The clinical evaluation of hirsutism by Somani N1, Harrison S, Bergfeld WF.(PubMed)
(8) Polycystic ovary syndrome and insulin: our understanding in the past, present and future by Mayer SB1, Evans WS, Nestler JE.(PubMed)
(9) Association of mean platelet volume with androgens and insulin resistance in nonobese patients with polycystic ovary syndrome by Dogan BA1, Arduc A2, Tuna MM1, Karakılıc E1, Dagdelen I1, Tutuncu Y1, Berker D1, Guler S1.(PubMed)
(10) Approach to the patient: contraception in women with polycystic ovary syndrome by Yildiz BO1.(PubMed)
(11) Polycystic ovarian syndrome (PCOS): a significant contributor to the overall burden of type 2 diabetes in women by Talbott EO1, Zborowski JV, Rager JR, Kip KE, Xu X, Orchard TJ.(PubMed)
(12) Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities by Figurová J1, Dravecká I, Javorský M, Petríková J, Lazúrová I.(PubMed)
(13) Role of Insulin Sensitizers on Cardiovascular Risk Factors in Polycystic Ovarian Syndrome: A Meta-Analysis by Thethi TK1, Katalenich B2, Nagireddy P3, Chabbra P4, Kuhadiya N5, Fonseca V1.(PubMed)
(14) Acne in hirsute women by Lumezi BG1, Pupovci HL1, Berisha VL1, Goçi AU2, Gerqari A3.(PubMed)
(15) Obesity and polycystic ovary syndrome by Naderpoor N1, Shorakae S, Joham A, Boyle J, De Courten B, Teede HJ.(PubMed)
(16) Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan by Teede H1, Deeks A, Moran L.(PubMed)
(17) Metabolic Evidence of Diminished Lipid Oxidation in Women WithPolycystic Ovary Syndrome. by Whigham LD1, Butz DE2, Dashti H3, Tonelli M3, Johnson LK1, Cook ME2, Porter WP4, Eghbalnia HR5, Markley JL6, Lindheim SR7, Schoeller DA8, Abbott DH9, Assadi-Porter FM10.(PubMed)
(18) Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis by Barry JA1, Azizia MM1, Hardiman PJ2.(PubMed)
(19) Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study by Gottschau M1, Kjaer SK2, Jensen A1, Munk C1, Mellemkjaer L3.(PubMed)
(20) Polycystic ovary syndrome: metabolic consequences and long-term management by Carmina E1.(PubMed)
(21) Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype by Armeni E1, Stamatelopoulos K, Rizos D, Georgiopoulos G, Kazani M, Kazani A, Kolyviras A, Stellos K, Panoulis K, Alexandrou A, Creatsa M, Papamichael C, Lambrinoudaki I.(PubMed)
(1246) [Clinical study of area of Jiangsu province of polycystic ovarian syndrome correlation distribution of traditional Chinese medicine syndrome type and improper diet]. [Article in Chinese] by Feng Y, Gao YP.(PubMed)
(1247) [Preliminary study on relationship of disease-syndrome-symptom of ovulatory disorder infertility based on factor analysis]. [Article in Chinese] by Li M, Ma K, Shan, J.(PubMed)
(1247a) A Comprehensive Treatment of Polycystic Ovarian Syndrome (PCOS) bny by Liqin Zhao
(2072) Spleen, Earth
(2073) [Research on building method of spleen kidney Yang deficiency diarrhea rats model]. [Article in Chinese] by Pan X, Hu CJ, Geng YY, Zhao L, Wu WH, Wu XQ, Zhong ZD.(PubMed)
(2074) Treatment of an elderly patient with acute abdominal pain with traditional Korean medicine by Son CG1.(PubMed)
(2075) Shenzhu Tiaopi granule combined with lifestyle intervention therapy for impaired glucose tolerance: a randomized controlled trial by Fang Z1, Zhao J2, Shi G3, Shu Y3, Ni Y3, Wang H3, Ding L3, Lu R3, Li J3, Zhu X3, Cheng S4, Zhang X3, Liu Y5, Wang J6, Luo Y3, Fan Q3, Guo C3, Jiang T3, Wu Q3, Fan L3, Ling H3, Cui L3, Luo Y3, Yang H3, Anderson RM7.(PubMed)
(2075) Direct moxibustion to treat spleen qi and yang deficiency fatigue: a pilot study by Thorne TL1, Hanes DA2, Wild H3, Colbert A4.(PubMed)
(2076) [Clinical observation on fuzhong (supporting the middle-jiao) manipulation of tuina for infantile anorexia]. [Article in Chinese] by Wang YY, Liu XY.(PubMed)
(2077) [Effect of umbilicus moxibustion therapy on physical conditions of yang-deficiency volunteers]. [Article in Chinese] by Zhang YY1.(PubMed)
(2078) Analysis of the restorative effect of Bu-zhong-yi-qi-tang in the spleen-qi deficiency rat model using (1)H-NMR-based metabonomics by Zheng XF1, Tian JS2, Liu P3, Xing J1, Qin XM1.(PubMed)
(2079) [1H NMR based metabolomics study of bu-zhong-yi-qi-tang in the spleen-qi deficiency rat model]. [Article in Chinese] by Chen L, Xiang H, Xing J, Tian JS, Qin XM, Du GH.(PubMed)
(2080) Bufei Jianpi granules improve skeletal muscle and mitochondrial dysfunction in rats with chronic obstructive pulmonary disease by Dong Y1,2, Li Y3,4,5, Sun Y6, Mao J7, Yao F8, Tian Y9, Wang L10, Li L11, Li S12,13,14, Li J15,16,17(PubMed)
(2081) [Clinical observation on obesity and hyperlipidemia of liver qi stagnation and spleen deficiency pattern in female patients treated with combined therapy of acupuncture and tapping method]. [Article in Chinese] by Wu B, Liu ZC, Xu B.(PubMed)
(2117) Jiang huang(Complementary and Alternative Healing University)
(2118) Effects of ingested turmeric oleoresin on glucose and lipid metabolisms in obese diabetic mice: a DNA microarray study by Honda S1, Aoki F, Tanaka H, Kishida H, Nishiyama T, Okada S, Matsumoto I, Abe K, Mae T.(PubMed)
(2119) Herbal composition Gambigyeongsinhwan (4) from curcuma longa, Alnus japonica, and massa Medicata Fermentata inhibits lipid accumulation in 3T3-L1 cells and regulates obesity in Otsuka long-Evans Tokushima fatty rats by Sung Roh J1, Lee H2, Woo S2, Yoon M2, Kim J2, Dong Park S3, Shik Shin S4, Yoon M5.(PubMed)
(2120) Efficacy of turmeric (curcumin) in pain and postoperative fatigue after laparoscopic cholecystectomy: a double-blind, randomized placebo-controlled study by Agarwal KA1, Tripathi CD, Agarwal BB, Saluja S.(PubMed)
(2121) Intrathecal curcumin attenuates pain hypersensitivity and decreases spinal neuroinflammation in rat model of monoarthritis by Chen JJ1, Dai L2, Zhao LX3, Zhu X4, Cao S4, Gao YJ3.(PubMed)
(2122) Turmeric extracts containing curcuminoids prevent experimental rheumatoid arthritis by Funk JL1, Oyarzo JN, Frye JB, Chen G, Lantz RC, Jolad SD, Sólyom AM, Timmermann BN.(PubMed)
(2123) Efficacy and mechanism of action of turmeric supplements in the treatment of experimental arthritis by Funk JL1, Frye JB, Oyarzo JN, Kuscuoglu N, Wilson J, McCaffrey G, Stafford G, Chen G, Lantz RC, Jolad SD, Sólyom AM, Kiela PR, Timmermann BN.(PubMed)
(2124) Comparative evaluation of single application of 2% whole turmeric gel versus 1% chlorhexidine gel in chronic periodontitis patients: A pilot study by Jaswal R1, Dhawan S1, Grover V1, Malhotra R1.(PubMed)
(2125) Evaluation of local drug-delivery system containing 2% whole turmeric gel used as an adjunct to scaling and root planing in chronic periodontitis: A clinical and microbiological study by Behal R1, Mali AM, Gilda SS, Paradkar AR.(PubMed)
(2126) Chemopreventive effect of turmeric against stomach and skin tumors induced by chemical carcinogens in Swiss mice by Azuine MA1, Bhide SV.(PubMed)
(2127) Adjuvant chemoprevention of experimental cancer: catechin and dietary turmeric in forestomach and oral cancer models by Azuine MA1, Bhide SV.(PubMed)
(2128) Combination Efficacy of Astragalus membranaceus and Curcuma wenyujin at Different Stages of Tumor Progression in an Imageable Orthotopic Nude Mouse Model of Metastatic Human Ovarian Cancer Expressing Red Fluorescent Protein by Yin G1, Tang D2, Dai J1, Liu M1, Wu M1, Sun YU3, Yang Z4, Hoffman RM5, Li L1, Zhang S1, Guo X1.(PubMed)
(2129) Curcumin inhibits herpes simplex virus immediate-early gene expression by a mechanism independent of p300/CBP histone acetyltransferase activity by Kutluay SB1, Doroghazi J, Roemer ME, Triezenberg SJ.(PubMed)
(2130) Downregulation of cellular c-Jun N-terminal protein kinase and NF-κB activation by berberine may result in inhibition of herpes simplex virus replication by Song S1, Qiu M1, Chu Y1, Chen D1, Wang X1, Su A1, Wu Z2.(PubMed)
(2131) Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis by Sahebkar A1.(PubMed)
(2132) Therapeutic roles of curcumin: lessons learned from clinical trials by Gupta SC1, Patchva S, Aggarwal BB.(PubMed)
(2133) Spicing up endogenous neural stem cells: aromatic-turmerone offers new possibilities for tackling neurodegeneration by Poser SW, Androutsellis-Theotokis A.(PubMed)
(2134) Aromatic-turmerone induces neural stem cell proliferation in vitro and in vivo by Hucklenbroich J1,2, Klein R3,4, Neumaier B5, Graf R6, Fink GR7,8, Schroeter M9,10,11, Rueger MA12,13,14.(PubMed)
(2135) Turmeric and green tea: a recipe for the treatment of B-chronic lymphocytic leukemia by Angelo LS1, Kurzrock R.(PubMed)
(2136) Curcumin inhibits prosurvival pathways in chronic lymphocytic leukemia B cells and may overcome their stromal protection in combination with EGCG by Ghosh AK1, Kay NE, Secreto CR, Shanafelt TD.(PubMed)
(2137) Clinical efficacy of the co-administration of Turmeric and Black seeds (Kalongi) in metabolic syndrome - a double blind randomized controlled trial - TAK-MetS trial by Amin F1, Islam N2, Anila N3, Gilani AH4.(PubMed)
(2138) Effect of a Natural Supplement Containing Curcuma Longa, Guggul, and Chlorogenic Acid in Patients With Metabolic Syndrome by Patti AM1, Al-Rasadi K2, Katsiki N3, Banerjee Y4, Nikolic D1, Vanella L5, Giglio RV1, Giannone VA1, Montalto G1, Rizzo M6.(PubMed)
(2139) Hypoglycemic, hypolipidemic and antioxidant properties of combination ofCurcumin fromCurcuma longa, Linn, and partially purified product fromAbroma augusta, Linn. in streptozotocin induced diabetes by Ali Hussain HE1.(PubMed)
(2140) [Screening of pancreatic lipase and alpha-glucosidase inhibitors from Chinese dietary herbs]. [Article in Chinese] by Sun X1, Zhang K, Ji X, Wang Y, Jeffrey Z, Tong Y, Gao H, Zhang J, Wang Z.(PubMed)
(2141) Effect of curcumin on hepatic heme oxygenase 1 expression in high fat diet fed rats: is there a triangular relationship? by Öner-İyidoğan Y1, Tanrıkulu-Küçük S, Seyithanoğlu M, Koçak H, Doğru-Abbasoğlu S, Aydin AF, Beyhan-Özdaş Ş, Yapişlar H, Koçak-Toker N.(PubMed)
(2142) Short-term effect of G-400, polyherbal formulation in the management of hyperglycemia and hyperlipidemia conditions in patients with type 2 diabetes mellitus by Kurian GA1, Manjusha V2, Nair SS2, Varghese T2, Padikkala J3.(PubMed)
(2143) Anti-hyperglycemic and insulin sensitizer effects of turmeric and its principle constituent curcumin by Ghorbani Z1, Hekmatdoost A2, Mirmiran P3.(PubMed)
(2144) Improvements of insulin resistance in ovariectomized rats by a novel phytoestrogen from Curcuma comosa Roxb by Prasannarong M1, Saengsirisuwan V, Piyachaturawat P, Suksamrarn A.(PubMed)
(2145) Antioxidant and vascular protective effects of curcumin and tetrahydrocurcumin in rats with L-NAME-induced hypertension. Nakmareong S1, Kukongviriyapan U, Pakdeechote P, Donpunha W, Kukongviriyapan V, Kongyingyoes B, Sompamit K, Phisalaphong C.(PubMed)
(2146) Curcumin protects against cadmium-induced vascular dysfunction, hypertension and tissue cadmium accumulation in mice. Kukongviriyapan U1, Pannangpetch P2, Kukongviriyapan V3, Donpunha W4, Sompamit K5, Surawattanawan P6.(PubMed)
(2147) Anti-obesity effect of a standardised ethanol extract from Curcuma longa L. fermented with Aspergillus oryzae in ob/ob mice and primary mouse adipocytes by Ho JN1, Jang JY, Yoon HG, Kim Y, Kim S, Jun W, Lee J.(PubMed)
(2148) Serum metabonomic analysis of protective effects of Curcuma aromatica oil on renal fibrosis rats by Zhao L1, Zhang H1, Yang Y2, Zheng Y1, Dong M1, Wang Y1, Bai G3, Ye X3, Yan Z3, Gao H4.(PubMed)
(2149) Improvements of insulin resistance in ovariectomized rats by a novel phytoestrogen from Curcuma comosa Roxb by Prasannarong M1, Saengsirisuwan V, Piyachaturawat P, Suksamrarn A.(PubMed)
(2150) Turmerin: a water soluble antioxidant peptide from turmeric [Curcuma longa].by Srinivas L1, Shalini VK, Shylaja M.(PubMed)
(2151) Antiproliferative, protective and antioxidant effects of artichoke, dandelion, turmeric and rosemary extracts and their formulation by Menghini L1, Genovese S, Epifano F, Tirillini B, Ferrante C, Leporini L.(PubMed)
(2152) Associations between Dietary Antioxidant Intake and Metabolic Syndrome by Wei J1, Zeng C2, Gong QY1, Li XX1, Lei GH2, Yang TB1.(PubMed)
(2153) Inflammatory markers and cardiometabolic diseases by Esser N, Paquot N, Scheen AJ.(PubMed)
(2154) Human resistin and the RELM of Inflammation in diabesity by Al Hannan F1, Culligan KG2.(PubMed)
(2155) Protective effects of ginger-turmeric rhizomes mixture on joint inflammation, atherogenesis, kidney dysfunction and other complications in a rat model of human rheumatoid arthritis by Ramadan G1, El-Menshawy O.(PubMed)
No comments:
Post a Comment